Hal Hirte
Impact in
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
-
- Clusterin in disease pathology
- Neutropenia and Cancer Infections
Papers in
-
- Ovarian cancer diagnosis and treatment 5
- Oncology 2
- Cancer Immunotherapy and Biomarkers 1
- Clusterin in disease pathology 1
- Co-authors
- Sebastién J. Hotte (2 shared papers)Laurie M. Elit (1 shared paper)Wendy Walsh (1 shared paper)Kim N. Chi (1 shared paper)Lillian L. Siu (1 shared paper)Emma S. Tomlinson Guns (1 shared paper)Martin Edwin Gleave (1 shared paper)Dongsheng Tu (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)Clinical Cancer Research (1 paper)Current Opinion in Obstetrics & Gynecology (1 paper)Gynecologic Oncology (1 paper)EClinicalMedicine (1 paper)
- Partner nations
- CanadaNew ZealandBelgium
In The Last Decade
Hal Hirte
8 papers receiving 282 citations
Peers
Comparison fields: 5 of 36
- Obstetrics and Gynecology 38
- Oncology 77
- Reproductive Medicine 30
- Hematology 21
- Hepatology 13
Countries citing papers authored by Hal Hirte
This map shows the geographic impact of Hal Hirte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal Hirte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal Hirte more than expected).
Fields of papers citing papers by Hal Hirte
This network shows the impact of papers produced by Hal Hirte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal Hirte. The network helps show where Hal Hirte may publish in the future.
Co-authors
The 25 scholars most cited alongside Hal Hirte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 103 | |
| 2 | 2002 | 91 | |
| 3 | 2002 | 42 | |
| 4 | 1991 | 23 | |
| 5 | An international multicentre Phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/Paclitaxel + Platinum containing chemotherapy (CT) | 2001 | 15 |
| 6 | 1993 | 10 | |
| 7 | Aflibercept (VEGF TRAP) in advanced ovarian cancer patients with recurrent symptomatic malignant ascites: results of a randomized, double-blind, placebo-controlled study | 2009 | 7 |
| 8 | 1991 | 2 | |
| 9 | 2024 | 2 |
About Hal Hirte
Hal Hirte is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Molecular Biology and Nuclear Energy and Engineering, having authored 9 papers that have together received 295 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Clusterin in disease pathology (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Obstetrics and Gynecology (38 citations), Oncology (77 citations), Reproductive Medicine (30 citations), Hematology (21 citations) and Hepatology (13 citations). Hal Hirte has collaborated with scholars based in Canada, New Zealand and Belgium. Frequent co-authors include Sebastién J. Hotte, Laurie M. Elit, Wendy Walsh, Kim N. Chi, Lillian L. Siu, Emma S. Tomlinson Guns, Martin Edwin Gleave, Dongsheng Tu, Jean Powers and Elizabeth A. Eisenhauer. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Clinical Cancer Research, Current Opinion in Obstetrics & Gynecology, Gynecologic Oncology and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.